HSL Mobile App 
52 week Low
405.00
405.00
52 week High
1,069.95
1,069.95
681.40
Day low
656.25
656.25
Day high
687
687
681.40
Prev Close
659.55
659.55
Open
669.90
669.90
6M return
-19.69%
-19.69%
1Y return
45.75%
45.75%
MCap(Rs. in Cr.)
703.35
703.35
Total Volume
6,649
6,649
Face Value : 10
Listed Since 18 Jul 2016
PE Ratio
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
P/E RATIO
20.05473
EPS
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
EPS
33.80
PRICE/BOOK
Price-to-book ratio is used to compared the company's current market price with its book value.
PRICE/BOOK
2.94
Deliverable
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
DELIVERABLES
68.09%
DIV YIELD.(%)
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
DIV YIELD.(%)
0.00
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
Resistance 1
-
-
Resistance 2
-
-
Support 1
-
-
Support 2
-
-
Moving Average
20 Days
-
-
50 Days
-
-
100 Days
-
-
200 Days
-
-
Growth in 3 years
Sales
-32.67%
Sales Industry Avg
17.49%
PAT
-80.31%
PAT Industry Avg
38.55%
-32.67%
Sales Industry Avg
17.49%
PAT
-80.31%
PAT Industry Avg
38.55%
| Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
|---|---|---|---|---|---|
| Sales | 84.41 | 90.03 | 80.08 | 91.98 | 307.17 |
| Gross Profit | 15.95 | 17.18 | 15.14 | 11.05 | 50.66 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11.39 | 12.53 | 11.15 | 5.81 | 31.10 |
| Tax | 2.87 | 4.07 | 2.80 | 1.57 | 7.48 |
| Profit After Tax | 8.52 | 8.46 | 8.35 | 4.24 | 23.62 |
Growth in 3 years
Total Asset Growth
36.71%
Total Liabilities growth
37.17%
Reserves Change
25.22%
36.71%
Total Liabilities growth
37.17%
Reserves Change
25.22%
| Mar 2024 ( in Cr.) | Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2020 ( in Cr.) | |
|---|---|---|---|---|---|
| Share Capital | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| Reserves And Surplus | 213.84 | 190.14 | 170.77 | 50.78 | 35.63 |
| Investments | 0 | 0 | 0 | 5.17 | 3.99 |
| Total Debt | 98.12 | 90.27 | 54.01 | 41.23 | 34.97 |
| Total Liabilities | 320.71 | 289.34 | 233.81 | 101.09 | 79.94 |
| Total Assets | 308.49 | 278.59 | 225.66 | 110.76 | 89.62 |
No data available
Relative to Sensex rtn in 3 year
123.64%
Relative to Nifty rtn in 3 year
109.64%
Relative to top 3 MF rtn in 3 year
123.64%
Relative to Nifty rtn in 3 year
109.64%
Relative to top 3 MF rtn in 3 year
| 1 Year (%) | 2 Year (%) | 3 Year (%) | |
|---|---|---|---|
| Kwality Pharma | 46 | 113 | 69 |
| Bse Sensex | 0 | 27 | 31 |
| Nifty 50 | 0 | 31 | 33 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Kwality Pharma
681.40 chg : 21.85 (3.31%)
681.40 chg : 21.85 (3.31%)
Emcure Pharma
926.00 chg : 926.00 (0.00%)
926.00 chg : 926.00 (0.00%)
Blue Jet Health
840.00 chg : 2.10 (0.25%)
840.00 chg : 2.10 (0.25%)
Sai Life
696.60 chg : -0.45 (-0.06%)
696.60 chg : -0.45 (-0.06%)
Sanofi Consumer
4880.00 chg : -11.75 (-0.24%)
4880.00 chg : -11.75 (-0.24%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
My investment would be worth 1,45,754.00 with a Gain of 45.75%
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
No data available
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
No data available
Our Research Analysis
As of today
__PERCENT__%
Target Achived
__PERCENT__%
Target Achived
This call still has potential to give significant positive returns
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
CMP : __CMP__
Target : __TARGET__
Stop Loss : __STOPLOSS__
Reco Price : __RECOPRICE__
Reco Date :__RECODATE__
Call Type :__CALLTYPE__
__Rationale__
__RECOTYPE__ __COMPANY_NAME__
|
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
Our View __RECOTYPE__
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
| No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
| Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
|---|---|---|---|
| No data available | |||
News
Stay tuned to the latest developments and happenings in the company.
Kwality Pharmaceuticals consolidated net profit rises 10.92% in the December 2024 quarter
Net profit of Kwality Pharmaceuticals rose 10.92% to Rs 8.53 crore in the quarter ended December 2024 as against Rs 7.69 crore during the previous qua....
01 Feb 2025 07:44Kwality Pharmaceuticals to discuss results
Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live....
21 Jan 2025 11:06Kwality Pharmaceuticals update on pre-clinical studies of Erythropoietin
Kwality Pharmaceuticals (KPL) has secured approval from the Review Committee on Genetic Manipulation (RCGM) to commence pre-clinical toxicity ....
02 Jan 2025 15:37Kwality Pharmaceuticals consolidated net profit rises 35.74% in the September 2024 quarter
Net profit of Kwality Pharmaceuticals rose 35.74% to Rs 8.47 crore in the quarter ended September 2024 as against Rs 6.24 crore during the previous qu....
31 Oct 2024 07:33Kwality Pharmaceuticals to hold board meeting
Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live....
23 Oct 2024 10:21Kwality Pharmaceuticals consolidated net profit rises 54.24% in the June 2024 quarter
Net profit of Kwality Pharmaceuticals rose 54.24% to Rs 8.36 crore in the quarter ended June 2024 as against Rs 5.42 crore during the previous quarter....
12 Aug 2024 07:32__heading__
Published on __date__ at __time__
__description__
